CMSC: Consortium of Multiple Sclerosis Centers
Conference Coverage
Steroid-induced psychosis in MS? Quetiapine may help
Popular antipsychotic helped Canadian patients recover from psychiatric distress.
Conference Coverage
Influenza vaccine efficacy called undiminished in MS
Meta-analysis results are consistent with latest AAN immunization guideline.
Conference Coverage
CMSC MRI guidelines evolve into international consensus protocol
Internationally accepted consensus guidelines will improve lagging conformity with the recommendations.
Conference Coverage
Cannabis misconceptions still common among MS clinicians
Studies and surveys underscore that misconceptions about cannabis could be common among clinicians and patients.
Conference Coverage
Function in MS may vary significantly within EDSS scores
Mean normalized velocity of preferred walking speed may vary by more than 20% within EDSS groups and overlap by more than 20% between groups.
Conference Coverage
Herpes zoster infection with MS treatment higher in women?
While MS affects more women than men, the fivefold increase in HZV well exceeds the female-male ratio in MS.
Conference Coverage
Newest oral DMTs haven’t yet made a big impact in the MS world
“Now there are six oral DMTs competing among themselves for a relatively limited pool of patients.”
Conference Coverage
Constraint-induced movement therapy may boost neuroplasticity in MS
For patients with asymmetric upper limb nonuse, the treatment “is highly successful for promoting increased use by the more-affected arm.”
Conference Coverage
Telerehabilitation may be effective in MS
Patients with MS may achieve equivalent benefits and increased cost savings with telerehabilitation, compared with outpatient rehabilitation.
Conference Coverage
Ofatumumab shows high elimination of disease activity in MS
The once-per-month self-injected therapy could offer an alternative to DMTs that require in-office infusion.
Conference Coverage
Natalizumab switch to moderate-efficacy DMT increases disability risk
“Patients transitioning from natalizumab to another high-efficacy therapy have better inflammatory and disability outcomes, compared with those...
Medical Education Library
MS Highlights From the AAN & CMSC Annual Meetings
Conference Coverage
Black holes are associated with impaired cognition in MS
SEATTLE – Patients with MS and at least one black hole have poorer cognitive processing speed and visuospatial...
Conference Coverage
Functional GI disorders are common in MS
SEATTLE – In patients with MS, the prevalence of functional GI disorders increases with increasing disability.
Conference Coverage
Neutrophils may decline in patients on fingolimod
SEATTLE – Levels of these innate immune cells decreased in patients who had been on the drug for years, and this finding warrants further research...